2022-2027 Global Transfusion Diagnostics Market Opportunities, 2022 Shares and Five-Year Forecasts in the US, Europe, Japan - Immunohematology and Infectious Disease Screening - Analyzers and Reagents, Competitive Analysis, Growth Strategies, Volume and S

2022-2027 Global Transfusion Diagnostics Market Opportunities, 2022 Shares and Five-Year Forecasts in the US, Europe, Japan - Immunohematology and Infectious Disease Screening - Analyzers and Reagents, Competitive Analysis, Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks

The report is available by geographic region, country, market segment, test category, section, and individual assay.

This comprehensive seven- country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in the US, Europe and Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Group Genotyping

PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing

Microarrays

BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG,  C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates for leading suppliers of blood typing, grouping and infectious disease screening tests by country and individual product.

Geographic Regions

Europe
France
Germany
Italy
Spain
UK

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, M&A, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.

- Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment:

- Blood Centers
- Plasma Fractionation Facilities
- Hospitals
- Commercial/Private Laboratories
- Military Blood Banks

Current and Emerging Products

- Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays.

- Review of automated and semi-automated molecular and immunohematology analyzers.

strong>Technology Review

- Assessment of current and emerging technologies, and their potential applications for the blood banking market.

- Comprehensive lists of companies developing or marketing new technologies and products, by test.

Worldwide Market Overview

- Estimates of facilities performing blood banking tests, by country.

- Test volume and sales projections by country.

Strategic Recommendations

- New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.